Menu
1-702-720-6310 info@microcapspecualtors.com

11:47 am Stemline Therapeutics SL-401 Phase 2 BPDCN trial results to be presented at the EHA meeting this weekend; to continue to enroll first-line and relapsed/refractory patients in this ongoing trial

Source: New feed

Search